Status:
COMPLETED
Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum Hemorrhage
Lead Sponsor:
Aswan University Hospital
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
The objective of this study is to compare the effectiveness and safety of carbetocin vs. oxytocin plus sublingual misoprostol in the management of atonic postpartum hemorrhage (PPH)after vaginal deliv...
Detailed Description
The first cause of hemorrhage at the time of delivery is uterine atony; therefore, there is general agreement that active management of the third stage of labor is recommended. Oxytocin is the most w...
Eligibility Criteria
Inclusion
- All participants had PPH defined as vaginal bleeding\>500 ml after vaginal delivery and uterine atony confirmed by abdominal palpation
Exclusion
- gestational age\<37 weeks,
- genital tract trauma,
- coagulation defect,
- women with hypertension, preeclampsia, cardiac, renal or liver diseases, epilepsy
- known hypersensitivity to carbetocin or oxytocin.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT03870503
Start Date
April 1 2019
End Date
August 1 2021
Last Update
September 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University Hospital
Aswān, Egypt, 81528